ES2260906T3 - Tratamiento de hipertension iatrogenica y relacionada con la edad con derivados de vitamina b6 y composiciones farmaceuticas utiles en el mismo. - Google Patents

Tratamiento de hipertension iatrogenica y relacionada con la edad con derivados de vitamina b6 y composiciones farmaceuticas utiles en el mismo.

Info

Publication number
ES2260906T3
ES2260906T3 ES99915411T ES99915411T ES2260906T3 ES 2260906 T3 ES2260906 T3 ES 2260906T3 ES 99915411 T ES99915411 T ES 99915411T ES 99915411 T ES99915411 T ES 99915411T ES 2260906 T3 ES2260906 T3 ES 2260906T3
Authority
ES
Spain
Prior art keywords
nsaid
vitamin
group
hypertension
indomethacin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99915411T
Other languages
English (en)
Spanish (es)
Inventor
Krishnamurti Dakashinamurti
Rajat Sethi
Naranjan S. Dhalla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Manitoba
Medicure Inc
Original Assignee
University of Manitoba
Medicure Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Manitoba, Medicure Inc filed Critical University of Manitoba
Application granted granted Critical
Publication of ES2260906T3 publication Critical patent/ES2260906T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ES99915411T 1998-04-16 1999-04-16 Tratamiento de hipertension iatrogenica y relacionada con la edad con derivados de vitamina b6 y composiciones farmaceuticas utiles en el mismo. Expired - Lifetime ES2260906T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61173 1998-04-16
US09/061,173 US6051587A (en) 1998-04-16 1998-04-16 Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein

Publications (1)

Publication Number Publication Date
ES2260906T3 true ES2260906T3 (es) 2006-11-01

Family

ID=22034118

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99915411T Expired - Lifetime ES2260906T3 (es) 1998-04-16 1999-04-16 Tratamiento de hipertension iatrogenica y relacionada con la edad con derivados de vitamina b6 y composiciones farmaceuticas utiles en el mismo.

Country Status (12)

Country Link
US (1) US6051587A (https=)
EP (1) EP1071430B1 (https=)
JP (1) JP2002512194A (https=)
AT (1) ATE319457T1 (https=)
AU (1) AU765749B2 (https=)
BR (1) BR9909672A (https=)
CA (1) CA2328730C (https=)
DE (1) DE69930243T2 (https=)
ES (1) ES2260906T3 (https=)
IL (1) IL139681A0 (https=)
NZ (1) NZ508142A (https=)
WO (1) WO1999053928A1 (https=)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716858B1 (en) 1995-08-28 2004-04-06 Kansas University Medical Center Methods for inhibiting diabetic complications
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
US6339085B1 (en) 1999-03-08 2002-01-15 The University Of Manitoba Therapeutics for cardiovascular and related diseases
US6489345B1 (en) * 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
EP1872797A3 (en) 1999-08-24 2008-04-02 Medicure International Inc. Treatment of cardiovascular and related pathologies
EP1531157B1 (en) * 2000-02-29 2008-03-19 Medicure International Inc. Cardioprotective phosphonates
US7442689B2 (en) 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
AU3718501A (en) 2000-02-29 2001-09-12 Medicure Int Inc Cardioprotective phosphonates and malonates
WO2001072309A2 (en) 2000-03-28 2001-10-04 Medicure International Inc. Treatment of cerebrovascular disease
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
WO2002039994A2 (en) 2000-11-20 2002-05-23 University Of Kansas Medical Center Methods for the treatment and prevention of urinary stone disease
US7723327B2 (en) 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
US7763649B2 (en) 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US7320997B2 (en) * 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US20050026874A1 (en) * 2002-07-29 2005-02-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US7345091B2 (en) * 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US20050059659A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid analogs or derivatives for controlling C-reactive protein levels
US20050004235A1 (en) * 2002-07-29 2005-01-06 Lockwood Samuel Fournier Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease
EP2392562B1 (en) 2002-07-29 2018-03-07 Cardax Pharma, Inc. Structural carotenoid analogs for the inhibition and amelioration of disease
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US20050049248A1 (en) * 2002-07-29 2005-03-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for controlling C-reactive protein levels
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
WO2004084910A1 (en) * 2003-03-27 2004-10-07 Medicure Inc. Compositions for treating angina
EP1610783A2 (en) * 2003-03-27 2006-01-04 Medicure Inc. Modulation of cell death
KR20060040676A (ko) * 2003-07-11 2006-05-10 미리어드 제네틱스, 인크. 알츠하이머병을 치료하기 위한 약제학적 방법, 투약 방법및 제형
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
EP1750723A1 (en) * 2004-04-14 2007-02-14 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
AU2005241023A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
US20060019929A1 (en) * 2004-07-07 2006-01-26 Albert Friesen Combination therapies employing platelet aggregation drugs
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
CA2575849A1 (en) * 2004-08-10 2006-02-16 Medicure International Inc. Combination therapies employing vitamin b6 related compounds and ace inhibitors and uses thereof for the treatment of diabetic disorders
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
WO2006050598A1 (en) * 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
EP1827455A1 (en) * 2004-11-26 2007-09-05 Medicure International Inc. Novel formulation of pyridoxal 5'-phosphate and method of preparation
JP2008526783A (ja) * 2005-01-05 2008-07-24 メディキュア・インターナショナル・インコーポレーテッド トリグリセリドレベルを調節するための化合物及び方法
CA2610502A1 (en) 2005-03-29 2006-10-05 Cardax Pharmaceuticals, Inc. Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof
CA2503087A1 (en) * 2005-03-30 2006-09-30 Medicure International Inc. Intravenous formulations of pyridoxal 5'-phosphate and method of preparation
KR20080039876A (ko) * 2005-07-22 2008-05-07 미리어드 제네틱스, 인크. 높은 약물 충진 제형 및 투여형
JP2009517411A (ja) * 2005-11-28 2009-04-30 メディキュア インターナショナル インコーポレーテッド 心血管及び関連病状の処置のための調剤
DOP2007000055A (es) 2006-04-10 2007-10-31 Senosiain S A De C V Lab Composición farmaceutica que comprende un analgésico y vitaminas
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
MX2008003230A (es) * 2008-03-07 2009-09-07 Senosiain S A De C V Lab Composicion famaceutica oral que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b.
ITMI20121316A1 (it) * 2012-07-27 2014-01-28 Altergon Sa Complessi di condroitina ad assorbimento transcutaneo
WO2014063134A1 (en) * 2012-10-19 2014-04-24 New York University Methods for inhibiting osteolysis
RU2629367C1 (ru) * 2016-11-02 2017-08-29 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Нестероидное противовоспалительное средство на основе напроксена, обладающее низкой гастротоксичностью

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4492M (https=) * 1965-07-07 1966-10-10
FR6707M (https=) * 1966-04-29 1969-02-17
FR6723M (https=) * 1966-12-30 1969-02-17
FR7503M (https=) * 1967-05-30 1969-12-08
GB1236531A (en) * 1969-02-12 1971-06-23 Soc D Etudes Prod Chimique Adenin derivative
JPS53121765A (en) * 1977-04-01 1978-10-24 Chugai Pharmaceut Co Ltd Pyridoxal derivatives
IL62602A (en) * 1980-05-19 1984-06-29 Labaz Sanofi Nv Pyridoxine derivatives,their preparation and pharmaceutical compositions containing them
US4542026A (en) * 1983-04-29 1985-09-17 Jose Rios Method of treating vasomotor disorders
US4564614A (en) * 1984-10-11 1986-01-14 Pfizer Inc. Antiinflammatory methods
FR2641189B1 (fr) * 1988-06-20 1991-05-10 Timol Mamoojee Compositions pharmaceutiques contenant de l'acide acetyl salicylique et de la vitamine b6
US20040180865A1 (en) * 1993-06-04 2004-09-16 Jeffry W. Kreamer Aspirin and vitamin and/or trace element compositions for the amelioration and treatment of vascular disease

Also Published As

Publication number Publication date
EP1071430A1 (en) 2001-01-31
CA2328730C (en) 2007-08-21
AU765749B2 (en) 2003-09-25
WO1999053928A1 (en) 1999-10-28
DE69930243D1 (de) 2006-05-04
CA2328730A1 (en) 1999-10-28
NZ508142A (en) 2002-11-26
BR9909672A (pt) 2007-07-31
AU3402999A (en) 1999-11-08
JP2002512194A (ja) 2002-04-23
US6051587A (en) 2000-04-18
IL139681A0 (en) 2002-02-10
ATE319457T1 (de) 2006-03-15
EP1071430B1 (en) 2006-03-08
DE69930243T2 (de) 2006-12-07

Similar Documents

Publication Publication Date Title
ES2260906T3 (es) Tratamiento de hipertension iatrogenica y relacionada con la edad con derivados de vitamina b6 y composiciones farmaceuticas utiles en el mismo.
ES2260773T3 (es) Tratamiento de los sintomas negativos y cognitivos de la esquizofreniacon antagonistas de la absorcion de glicina.
KR20100134032A (ko) 선별적 ｓ1ｐ₁ 수용체 작동약에 대한 투약 섭생
KR20040063913A (ko) 2-(4-이소부틸페닐)프로피온산의 약학 조성물
AU2013208649A1 (en) Combination therapy for the treatment of cancer
JPWO2013081154A1 (ja) キナーゼ阻害剤の副作用低減剤
FR2530469A1 (fr) Composition analgesique et anti-inflammatoire contenant de la cafeine
RS56591B1 (sr) (s)-pirlindol i njegove farmaceutski prihvatljive soli za upotrebu u medicini
ES2237625T3 (es) Uso de un derivado de hidantoina en una composicion farmaceutica contra la hipoalbuminemia.
ES2247060T3 (es) Producto que comprende un inhibidor de la transduccion de las señales de las proteinas g heterotrimericas en asociacion con un agente antihipertensor para una utilizacion terapeutica en el tratamiento de la hipertension arterial.
JP2002356445A (ja) 多発性硬化症（ｍｓ）、他の脱髄症状ならびに末梢神経障害、特に有痛の神経障害および糖尿病性神経障害の多剤併用治療
US20040180816A1 (en) Combination comprising a p-gp inhibitor and an anti-epileptic drug
KR100692235B1 (ko) 안지오텐신 ⅱ 길항물질의 신규한 용도
JP2015131849A (ja) 耐糖能異常用医薬組成物及び飲食品
JPH05310573A (ja) リウマチ治療薬
KR950703958A (ko) Hiv 감염증을 치료하기 위한,다른 비뉴클레오사이드 역 전사효소 억제제와 혼합된 bhap 화합물의 용도(use of bhap compounds in combination with other non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infection)
JPWO2005089743A1 (ja) 腎性貧血治療剤
Durivage et al. Prevention and management of toxicities associated with antineoplastic drugs
ES2332884T3 (es) Tratamiento de la lipodistrofia con inhibidores del sistema renina angiotensina.
RU2345775C1 (ru) Нестероидное противовоспалительное лекарственное средство
Wilke et al. Parenteral nitrogen mustard for inflammatory arthritis
EP3784243B1 (en) Methotrexate for use as a medicament
Lambova Treatment of Raynaud s Phenomenon
JPH0761942B2 (ja) 血中尿酸濃度の低下用医薬
JP2004026810A (ja) 鼻炎用組成物